Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6
Clinical trial NCT01468623 · TERMINATED
Trial details
- NCT number
- NCT01468623
- Sponsor
- Myriad Genetic Laboratories, Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-08-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.